Current medications have only a limited effect on two core symptoms of schizophrenia, negative symptoms and cognitive deficits. Minocycline is a second-generation tetracycline which has a beneficial effect in various neurological disorders. In the past years, various findings from clinical studies showed its potential role for the treatment of these symptoms of schizophrenia. The current study aims to examine the efficacy of minocycline as add-on treatment for alleviating positive, negative and cognitive symptoms in schizophrenia patients.The current study is a single center, double-blind, randomized study that assess the adjuvant therapeutic effect of minocycline vs. placebo added to antipsychotic medications, in adult patients suffering from schizophrenia. Patients will be recruited and randomly allocated to a minocycline or placebo treatment (200 mg/day) for 6 weeks of treatment. In addition, all patients will receive probiotics (450mg/day) in order to prevent any gastrointestinal influences of antibiotics administration. Positive and negative symptoms , as well as cognitive functions will be assessed before and after treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
40
Minocycline as an add-on drug (200 mg/day)
(200 mg/day)
(450 mg/day)
Bees Yaakov and Ness Ziona Mental Health Center
Beer Yaakov, Israel
RECRUITINGPositive and Negative Syndrome Scale (PANSS)
Time frame: Change in PANSS scores over the 6-weeks study
Scale for Assessment of Negative Symptoms (SANS)
Time frame: Change in SANS scores over the 6-weeks study
Clinical Global Impressions (CGI)
Time frame: Change in CGI scores over the 6-weeks study
The Montreal Cognitive Assessment (MoCa) task
Time frame: Change in MoCa scores over the 6-weeks study
Trail making task (TMT)
Time frame: Change in TMT scores over the 6-weeks study
Empathy Cartoon task
Time frame: Change in Empathy Cartoon task scores over the 6-weeks study
Interpersonal Reactivity Index (IRI) Questionnaire
Time frame: Change in IRI scores over the 6-weeks study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.